Cochlear Bulls Anticipate Implant Market-Share Gains -- Market Talk

Dow Jones
06/12

0650 GMT - Cochlear's bulls at Jefferies think the stock looks cheap given the market-share gains likely to follow the launch of its new hearing-implant system. They look past the short-term hit of downgraded profit expectations for the current fiscal year to highlight the potential benefits of the new system. They tell clients in a note that they had only expected two new products, so a system containing three is a positive. They say Cochlear's medium-term outlook is now stronger than previously assumed, with the new system's tech capability likely to resonate with surgeons. Jefferies lifts its target price 1.0% to A$3.11 and keeps a buy rating on the stock, which closed 0.7% higher at A$272.31. (stuart.condie@wsj.com)

 

(END) Dow Jones Newswires

June 12, 2025 02:50 ET (06:50 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10